Published in PLoS One on June 24, 2013
miR-191: an emerging player in disease biology. Front Genet (2014) 1.12
MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers. PLoS One (2015) 1.08
Comparison of hepatocellular carcinoma miRNA expression profiling as evaluated by next generation sequencing and microarray. PLoS One (2014) 0.97
TINAGL1 and B3GALNT1 are potential therapy target genes to suppress metastasis in non-small cell lung cancer. BMC Genomics (2014) 0.89
Universal disease biomarker: can a fixed set of blood microRNAs diagnose multiple diseases? BMC Res Notes (2014) 0.85
Principal component analysis-based unsupervised feature extraction applied to in silico drug discovery for posttraumatic stress disorder-mediated heart disease. BMC Bioinformatics (2015) 0.85
Cancer affects microRNA expression, release, and function in cardiac and skeletal muscle. Cancer Res (2014) 0.83
Identification of aberrant gene expression associated with aberrant promoter methylation in primordial germ cells between E13 and E16 rat F3 generation vinclozolin lineage. BMC Bioinformatics (2015) 0.82
Identification of More Feasible MicroRNA-mRNA Interactions within Multiple Cancers Using Principal Component Analysis Based Unsupervised Feature Extraction. Int J Mol Sci (2016) 0.81
Rare circulating microRNAs as biomarkers of colorectal neoplasia. PLoS One (2014) 0.81
Principal component analysis based unsupervised feature extraction applied to budding yeast temporally periodic gene expression. BioData Min (2016) 0.80
Studying the system-level involvement of microRNAs in Parkinson's disease. PLoS One (2014) 0.78
SFRP1 is a possible candidate for epigenetic therapy in non-small cell lung cancer. BMC Med Genomics (2016) 0.76
Principal Components Analysis Based Unsupervised Feature Extraction Applied to Gene Expression Analysis of Blood from Dengue Haemorrhagic Fever Patients. Sci Rep (2017) 0.75
Computational Analysis of Specific MicroRNA Biomarkers for Noninvasive Early Cancer Detection. Biomed Res Int (2017) 0.75
Genome-wide epigenomic profiling for biomarker discovery. Clin Epigenetics (2016) 0.75
Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A (2001) 132.88
A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity (2008) 5.89
Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila) (2011) 4.64
starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res (2010) 3.99
DIANA-mirPath: Integrating human and mouse microRNAs in pathways. Bioinformatics (2009) 3.05
Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer (2010) 2.95
Robust biomarker identification for cancer diagnosis with ensemble feature selection methods. Bioinformatics (2009) 2.66
Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev (2010) 2.51
Toward the blood-borne miRNome of human diseases. Nat Methods (2011) 2.14
Assessing the human immune system through blood transcriptomics. BMC Biol (2010) 1.86
PhenomiR: a knowledgebase for microRNA expression in diseases and biological processes. Genome Biol (2010) 1.79
MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels. PLoS One (2011) 1.79
Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis. Cancer Epidemiol (2011) 1.61
Positron emission tomography 18F-fluorodeoxyglucose uptake and prognosis in patients with surgically treated, stage I non-small cell lung cancer: a systematic review. J Thorac Oncol (2009) 1.57
Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development. Pathol Int (2010) 1.49
Development of the human cancer microRNA network. Silence (2010) 1.43
Unsupervised feature selection under perturbations: meeting the challenges of biological data. Bioinformatics (2007) 1.32
Analysis of serum genome-wide microRNAs for breast cancer detection. Clin Chim Acta (2012) 1.25
Screening and early detection of lung cancer. Cancer J (2011) 1.23
Next-generation sequencing identifies novel microRNAs in peripheral blood of lung cancer patients. Mol Biosyst (2011) 1.10
Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma. J Surg Oncol (2012) 1.07
Circulating microRNAs: potential biomarkers for cancer. Int J Mol Sci (2011) 1.02
An efficient semi-unsupervised gene selection method via spectral biclustering. IEEE Trans Nanobioscience (2006) 0.97
Blood-based miRNA preparation for noninvasive biomarker development. Methods Mol Biol (2012) 0.87
Circulating microRNAs as biomarkers - True Blood? Genome Med (2011) 0.82
Biomarkers of scleroderma lung disease: recent progress. Curr Rheumatol Rep (2011) 0.82
A marginal mixture model for selecting differentially expressed genes across two types of tissue samples. Int J Biostat (2008) 0.81
Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene. Oncogene (2003) 2.37
Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development. Pathol Int (2010) 1.49
Integration of hepatitis B virus DNA into the myeloid/lymphoid or mixed-lineage leukemia (MLL4) gene and rearrangements of MLL4 in human hepatocellular carcinoma. Hum Mutat (2008) 1.44
MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. Biomarkers (2009) 1.35
Polyubiquitin conjugation to NEMO by triparite motif protein 23 (TRIM23) is critical in antiviral defense. Proc Natl Acad Sci U S A (2010) 1.31
Identification and functional characterization of a new member of the human Mcm protein family: hMcm8. Nucleic Acids Res (2003) 1.23
Role of miR-19b and its target mRNAs in 5-fluorouracil resistance in colon cancer cells. J Gastroenterol (2012) 1.07
A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients. Cancer Chemother Pharmacol (2013) 1.04
Dysregulation of IFN system can lead to poor response to pegylated interferon and ribavirin therapy in chronic hepatitis C. PLoS One (2011) 0.98
Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan. J Med Virol (2004) 0.93
Universal disease biomarker: can a fixed set of blood microRNAs diagnose multiple diseases? BMC Res Notes (2014) 0.85
Prospective long-term study of hepatitis B virus reactivation in patients with hematologic malignancy. J Gastroenterol Hepatol (2014) 0.83
A deep-sequencing method detects drug-resistant mutations in the hepatitis B virus in Indonesians. Intervirology (2014) 0.80
Predictive value of early viral dynamics during peginterferon and ribavirin combination therapy based on genetic polymorphisms near the IL28B gene in patients infected with HCV genotype 1b. J Med Virol (2012) 0.80
Impact of genetic polymorphisms near the IL28B gene and amino acid substitutions in the hepatitis C virus core region on interferon sensitivity/resistance in patients with chronic hepatitis C. J Med Virol (2011) 0.78
Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients. J Hepatol (2007) 0.77
Positioning of 18F-fluorodeoxyglucose-positron emission tomography imaging in the management algorithm of hepatocellular carcinoma. J Gastroenterol Hepatol (2014) 0.76
Novel single nucleotide polymorphisms of the cytokeratin 19 pseudogene are associated with primary biliary cirrhosis. Hepatol Res (2003) 0.76
Association between hepatic steatosis and hepatic expression of genes involved in innate immunity in patients with chronic hepatitis C. Cytokine (2013) 0.76
Murine Herc6 Plays a Critical Role in Protein ISGylation In Vivo and Has an ISGylation-Independent Function in Seminal Vesicles. J Interferon Cytokine Res (2014) 0.75
Higher hepatic gene expression and serum levels of matrix metalloproteinase-2 are associated with steatohepatitis in non-alcoholic fatty liver diseases. Biomarkers (2012) 0.75
Molecular Dynamics Simulations to Determine the Structure and Dynamics of Hepatitis B Virus Capsid Bound to a Novel Anti-viral Drug. Chem Pharm Bull (Tokyo) (2016) 0.75
Impact of hepatitis B virus integration into liver tissue on the efficacy of peginterferon and ribavirin therapy in hepatitis B virus-negative chronic hepatitis C patients. J Clin Gastroenterol (2014) 0.75
Antiviral combination therapy with peginterferon and ribavirin does not induce a therapeutically resistant mutation in the HCV core region regardless of genetic polymorphism near the IL28B gene. J Med Virol (2011) 0.75
Pharmacokinetic properties of newly synthesized retinoid X receptor agonists possessing a 6-[N-ethyl-N-(3-alkoxy-4-isopropylphenyl)amino]nicotinic acid skeleton in rats. Drug Dev Ind Pharm (2011) 0.75
Characteristics of α-L-arabinofuranosidase from Streptomyces sp I10-1 for production of L-arabinose from corn hull arabinoxylan. Appl Biochem Biotechnol (2014) 0.75
Adjuvant epoetin-β with peginterferon-α and ribavirin in Japanese ribavirin-intolerant relapsed patients with chronic hepatitis C genotype 2. Hepatol Res (2013) 0.75